Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Mandas, Antonella ^a   Iorio, Eugenio Luigi ^b   Congiu, Maria Gabriella ^a   Balestrieri, Cinzia ^a   Mereu, Antonello ^a   Cau, Daniela ^a   Dessì, Sandra ^a   Curreli, Nicoletta ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b International Observatory of Oxidative Stress   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; CD4 ANTIGEN; EFAVIRENZ; FOSAMPRENAVIR; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ANTIOXIDANT; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; SMOKING; VIRUS LOAD; BLOOD; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIOXIDANTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SMOKING;

EID: 71149087271     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/749575     Document Type: Article

References (29)

1. Porter K., Survival after introduction of HAART in people with known duration of HIV-1 infection The Lancet 2000 355 9210 1158 1159
2. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Developed by the panel on clinical practices for treatment of HIV infection convened by Department of Health and Human Service (DHHS), http://AIDSinfo.nih.gov
3. Grabar S., Le Moing V., Goujard C., Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy Annals of Internal Medicine 2000 133 6 401 410
4. Fisher S. D., Miller T. L., Lipshultz S. E., Impact of HIV and highly active antiretroviral therapy on leucocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis Atherosclerosis 2006 185 1 11
5. Hadigan C., Diabetes, insulin resistance, and HIV Current Infectious Disease Reports 2006 8 1 69 75
6. Vervoort S. C. J. M., Borleffs J. C. C., Hoepelman A. I. M., Grypdonck M. H. F., Adherence in antiretroviral therapy: a review of qualitative studies AIDS 2007 21 3 271 281
7. Halliwell B., Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? The Lancet 1994 344 8924 721 724
8. Schreck R., Rieber P., Baeuerle P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF- B transcription factor and HIV-1 The EMBO Journal 1991 10 8 2247 2258
9. Kruman I. I., Nath A., Mattson M. P., HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress Experimental Neurology 1998 154 2 276 288
10. Martn J. A., Sastre J., De la Asuncin J., Pallard F. V., Vina J., Hepatic -cystathionase deficiency in patients with AIDS Journal of the American Medical Association 2001 285 11 1444 1445
11. Hulgan T., Morrow J., DAquila R. T., Oxidant stress is increased during treatment of human immunodeficiency virus infection Clinical Infectious Diseases 2003 37 12 1711 1717
12. Day B. J., Lewis W., Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo Cardiovascular Toxicology 2004 4 3 207 216
13. Kumar G. N., Dykstra J., Roberts E. M., Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug-drug interaction Drug Metabolism and Disposition 1999 27 8 902 908
14. Lewis W., Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions Antiviral Research 2003 58 3 189 197
15. Cossarizza A., Moyle G., Antiretroviral nucleoside and nucleotide analogues and mitochondria AIDS 2004 18 2 137 151
16. de La Asuncin J., del Olmo M. L., Sastre J., AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins The Journal of Clinical Investigation 1998 102 1 4 9
17. Drain P. K., Kupka R., Mugusi F., Fawzi W. W., Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy The American Journal of Clinical Nutrition 2007 85 2 333 345
18. Tang A. M., Lanzillotti J., Hendricks K., Micronutrients: current issues for HIV care providers AIDS 2005 19 9 847 861
19. Kirkham P. A., Spooner G., Ffoulkes-Jones C., Calvez R., Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor Free Radical Biology and Medicine 2003 35 7 697 710
20. Helmersson J., Larsson A., Vessby B., Basu S., Active smoking and a history of smoking are associated with enhanced prostaglandin F2, interleukin-6 and F2-isoprostane formation in elderly men Atherosclerosis 2005 181 1 201 207
21. Dohi K., Satoh K., Nakamachi T., Does Edaravone (MCI-186) act as an antioxidant and a neuroproctetor in experimental traumatic brain injury? Antioxid Redox Signal 2007 9 281 287
22. Trotti R., Carratelli M., Barbieri M., Oxidative stress and a thrombophilic condition alcoholics without severe liver disease Haematologica 2001 86 1 85 91
23. Pace G. W., Leaf C. D., The role of oxidative stress in HIV disease Free Radical Biology and Medicine 1995 19 4 523 528
24. Dobmeyer T. S., Findhammer S., Dobmeyer J. M., Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection Free Radical Biology and Medicine 1997 22 5 775 785
25. Gil L., Martnez G., Gonzlez I., Contribution to characterization of oxidative stress in HIV/AIDS patients Pharmacological Research 2003 47 3 217 224
26. Ngondi J. L., Oben J., Forkah D. M., Etame L. H., Mbanya D., The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon AIDS Research and Therapy 2006 3 1 19
27. Aberg J. A., Lipid management in patients who have HIV and are receiving HIV therapy Endocrinology and Metabolism Clinics of North America 2009 38 1 207 222
28. Maffei S., Mercuri A., Prontera C., Zucchelli G. C., Vassalle C., Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy Climacteric 2006 9 6 452 458
29. Ide T., Tsutsui H., Ohashi N., Greater oxidative stress in healthy young men compared with premenopausal women Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 438 442